Boston Scientific CFO Dan Brennan to Retire, Jon Monson to Succeed

Boston Scientific announced executive VP and chief financial officer (CFO) Dan Brennan is retiring after almost 30 years with the company. Brennan will move from the CFO position at the end of June, remaining as a senior adviser through early October 2025.

Current senior VP of investor relations Jon Monson will succeed Brennan as executive VP and CFO on June 30, 2025.

“I thank Dan for his incredible leadership and tremendous contributions to Boston Scientific,” said Mike Mahoney, chairman and CEO of Boston Scientific. “Dan is an exceptional leader, financial steward and teammate. He has been a critical leader on our global team as we have transformed the trajectory of BSX financial performance over many years. In addition to helping lead our highly differentiated financial performance, Dan has been central to building our strong values and culture. Throughout his career, he has been instrumental in developing talent within the financial organization. He and his team have overseen numerous strategic internal and external investment opportunities across our businesses since he assumed CFO responsibilities in 2014.”

Monson will be a member of the Executive Committee and have responsibility for global controllership, global internal audit, corporate finance, treasury, corporate tax, investor relations, and corporate business development.

Before leading investor relations at Boston Scientific, Monson had roles of increasing responsibility across the company’s finance, including five years as global controller and chief accounting officer. Before that, he served four years as VP and controller of the company’s Urology business.

As global controller, he helped lead the company in navigating through volatile financial period, including the 2020 pandemic.

“Jon is a proven leader who is known for his strategic mindset, diligent and thoughtful leadership and focus on high performance and continuous innovation,” said Mahoney. “Having been with Boston Scientific for more than 25 years, he brings broad financial experience and expertise across many areas of the company which will serve him well in his new role.”